Why is Wanbury Ltd ?
- Poor long term growth as Net Sales has grown by an annual rate of 7.57% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) of 3.36 times
- PBT LESS OI(Q) At Rs 4.23 cr has Fallen at -72.9% (vs previous 4Q average)
- PAT(Q) At Rs 3.24 cr has Fallen at -81.4% (vs previous 4Q average)
- ROCE(HY) Lowest at 25.32%
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -6.98%, its profits have risen by 38.4% ; the PEG ratio of the company is 0.7
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
How much should you hold?
- Overall Portfolio exposure to Wanbury should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Wanbury for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 44.30 cr has Grown at 26.68%
Lowest at 1.55 times
Highest at Rs 165.58 cr
At Rs 4.23 cr has Fallen at -72.9% (vs previous 4Q average
At Rs 3.24 cr has Fallen at -81.4% (vs previous 4Q average
Lowest at 25.32%
Lowest at 2.04 times
Lowest at 4.54 times
Lowest at Rs 16.24 cr.
Lowest at 9.81%
Lowest at Rs 0.93
Here's what is working for Wanbury
Net Sales (Rs Cr)
Debt-Equity Ratio
Here's what is not working for Wanbury
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Operating Profit to Interest
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
EPS (Rs)
Debtors Turnover Ratio






